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The plant hormone cytokinin affects a diverse array of growth and
development processes and responses to the environment. How a
signaling molecule mediates such a diverse array of outputs and how
these response pathways are integrated with other inputs remain
fundamental questions in plant biology. To this end, we character-
ized the transcriptional network initiated by the type-BARABIDOPSIS
RESPONSE REGULATORs (ARRs) that mediate the cytokinin primary
response, making use of chromatin immunoprecipitation sequenc-
ing (ChIP-seq), protein-binding microarrays, and transcriptomic ap-
proaches. By ectopic overexpression of ARR10, Arabidopsis lines
hypersensitive to cytokinin were generated and used to clarify the
role of cytokinin in regulation of various physiological responses.
ChIP-seq was used to identify the cytokinin-dependent targets for
ARR10, thereby defining a crucial link between the cytokinin
primary-response pathway and the transcriptional changes that me-
diate physiological responses to this phytohormone. Binding of
ARR10 was induced by cytokinin with binding sites enriched toward
the transcriptional start sites for both induced and repressed genes.
Three type-B ARR DNA-binding motifs, determined by use of
protein-binding microarrays, were enriched at ARR10 binding sites,
confirming their physiological relevance. WUSCHEL was identified
as a direct target of ARR10, with its cytokinin-enhanced expression
resulting in enhanced shooting in tissue culture. Results from our
analyses shed light on the physiological role of the type-B ARRs in
regulating the cytokinin response, mechanism of type-B ARR activa-
tion, and basis bywhich cytokinin regulates diverse aspects of growth
and development as well as responses to biotic and abiotic factors.
type-B ARR | two-component system | protein-binding microarray |
transcriptional cascade | WUSCHEL
Cytokinins are phytohormones that play critical roles throughoutplant growth and development (1–3). They were initially dis-
covered and named over a half-century ago based on their ability to
stimulate plant cell division in tissue culture (4). In the decades
since their discovery, they have been found to regulate a variety of
plant processes, including the stimulation of chloroplast develop-
ment, modulation of shoot and root development, delay of leaf
senescence, and regulation of metabolic processes, in particular
those related to source–sink relationships (1, 2). In addition, cyto-
kinins regulate plant responses to biotic and abiotic stresses (5–7).
The initial pathway for cytokinin signal transduction is a multi-
step phosphorelay that incorporates cytokinin receptors, histidine-
containing phosphotransfer proteins, and type-B response regula-
tors (1, 2). These relay the cytokinin signal from the membrane to
the nucleus, where the type-B response regulators function as tran-
scription factors to regulate gene expression. In Arabidopsis thaliana,
there are 3 cytokinin receptors (ARABIDOPSIS HISTIDINE
KINASEs; AHKs), 5 phosphotransfer proteins (ARABIDOPSIS
HISTIDINE-CONTAINING PHOSPHOTRANSFER PROTEINs;
AHPs), and 11 type-B response regulators (ARABIDOPSIS
RESPONSE REGULATORs; ARRs). Genetic analysis has dem-
onstrated roles for each of these families in a variety of cytokinin-
regulated processes.
The type-B ARRs mediate the primary transcriptional re-
sponse of Arabidopsis to cytokinin (8–11). The type-B ARRs
appear to function similar to prokaryotic response regulators,
many of which are also transcription factors (12). The type-B
ARRs contain the evolutionarily conserved receiver domain,
diagnostic for a response regulator, in their N-terminal region.
The C-terminal extensions are of variable length and contain a
DNA-binding Myb-like domain as well as sequences involved in
activation and nuclear localization (13, 14). The receiver do-
main is thought to inhibit transcriptional activity of the type-B
ARR because truncations that remove the receiver domain as
well as phosphomimic mutations in the receiver domain con-
stitutively activate cytokinin responses in planta (8, 14–16). Ge-
netic analysis indicates that the type-B ARR family members
ARR1, ARR10, and ARR12 play the most substantial roles in the
regulation of transcriptional and physiological responses to cyto-
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kinin (9–11). Protein levels of type-B ARRs are regulated in part
through the ubiquitin-proteasome pathway (15, 17, 18).
The response of the Arabidopsis transcriptome to cytokinin
has been characterized in over a dozen studies involving a va-
riety of plant growth conditions, tissues, and treatment regimes
(19, 20). Although we have extensive information on cytokinin-
regulated gene expression, we have only limited information on
which genes are direct targets of the type-B ARRs. Among the
genes most consistently induced in response to cytokinin are
the type-A ARRs, which encode a second family of response
regulators that negatively regulate cytokinin responses (21, 22).
The type-A ARRs are primary-response genes, based on the
ability of cytokinin to induce their expression in the presence of
cycloheximide (21). In addition, chromatin immunoprecipita-
tion has been used to identify binding sites of type-B ARRs
involved in regulation of the SHY2 and LAX2 genes to control
auxin responses (23, 24) and of PR1 and PR2 to control defense
responses (25), indicating that these are also primary-response
genes. These studies are consistent with transcriptional regu-
lation by the type-B ARRs, but the extent of such direct tran-
scriptional regulation in control of the cytokinin response
remains to be elucidated.
In this study, we took advantage of the enhanced stability of
ARR10 compared with the other type-B ARRs to generate
Arabidopsis lines hypersensitive to cytokinin and to clarify the role
of cytokinin in regulation of various physiological responses. We
also used protein-binding microarrays to characterize the DNA
binding sites for ARR1 and ARR10. Finally, we used chroma-
tin immunoprecipitation sequencing (ChIP-seq) to identify the
cytokinin-dependent targets for ARR10, thereby defining a crucial
link between the cytokinin primary-response pathway and the
transcriptional changes that mediate physiological responses to this
phytohormone. The findings from ChIP-seq also lend insight into
the mechanism by which type-B ARRs regulate gene expression,
and support the existence of a transcriptional cascade operating
downstream of the type-B ARRs.
Results
Elevated Expression of the Type-B Response Regulator ARR10 Results
in a Hypersensitive Response to Cytokinin. To explore the effects of
cytokinin hypersensitivity on Arabidopsis, we expressed ARR10 as a
GFP fusion driven by the CaMV 35S promoter in an arr1 arr10
arr12 loss-of-function mutant background. The rationale for this
strategy is as follows. First, ARR10 was used because it functionally
overlaps with ARR1 and ARR12 in playing a substantive role in
regulating the cytokinin transcriptional response, but the ARR10
protein is likely more stable than these type-B ARRs (26). Second,
the arr1 arr10 arr12 background was used because this triple mutant
abolishes the majority of cytokinin-mediated gene expression and
renders the plant largely insensitive to cytokinin for physiological
responses (10, 11). The arr1 arr10 arr12 cytokinin-insensitive line
can therefore be used to assess functionality of the ARR10-GFP
fusion and also eliminates members of the type-B ARR family that
could compete with ARR10 for activation and binding sites. Third,
the CaMV 35S promoter was used to drive ectopic overexpression,
because the native expression of the type-B ARRs is low and likely
restrictive for signaling (26, 27). We also expressed 35S:ARR10:
GFP in a wild-type background for comparison. Analysis by qRT-
PCR confirmed that the four lines in the arr1 arr10 arr12 back-
ground (lines a1, a2, a3, and a4) and the two lines in the wild-type
background (lines w1 and w2) exhibited substantially elevated ex-
pression of ARR10 compared with its native expression level in
wild type (Fig. 1A).
Analysis of hypocotyl and root growth responses to cytokinin
supports hypersensitivity of the 35S:ARR10:GFP transgenic
lines. Exogenous cytokinin inhibits hypocotyl growth in the dark
and primary root growth of wild-type seedlings, the arr1 arr12 and
arr1 arr10 arr12 mutants exhibiting cytokinin hyposensitivity or
insensitivity in these assays (Fig. 1 B and C). The ARR10:GFP
transgene is functional, as it restores cytokinin sensitivity to
arr1 arr10 arr12 in the root and hypocotyl assays as well as
rescues the mutant’s primary root abortion phenotype (Fig. 1 B
and C and Fig. S1) (10, 11). In the absence of cytokinin, two lines
(lines a1 and a3) in the arr1 arr10 arr12 background have shorter
hypocotyls and all four lines have shorter roots in the absence of
exogenous cytokinin than the wild type, consistent with an en-
hanced response to endogenous cytokinin levels. All four lines in
the arr1 arr10 arr12 background exhibit a substantially heightened
response in the presence of cytokinin (Fig. 1 B and D and Fig. S1).
The pronounced effects on root growth are due to a heightened
inhibition of cell expansion as well as of cell proliferation (Fig. 1 E
and F). Cytokinin hypersensitivity is also observed when 35S:
ARR10:GFP is expressed in the wild-type background, although
the effect of the transgene in the absence of exogenous cytokinin is
more pronounced in the arr1 arr10 arr12 background (Fig. 1 B and
C and Fig. S1).
Cytokinin is a positive regulator of cell proliferation and growth
in the shoot, contrasting with its negative regulation of cell pro-
liferation and growth in the primary root. Loss of type-B response
regulators (arr1 arr10 arr12mutant) results in a substantial decrease
in leaf size compared with wild type, this effect on growth in the
mutant being primarily due to a decrease in cell proliferation, al-
though a decrease in leaf cell area is also observed (Fig. S2 A and
B). Expression of 35S:ARR10:GFP in the arr1 arr10 arr12 back-
ground complemented the leaf growth phenotype of the mutant
(Fig. S2 A and C). In addition, the later larger leaves of the 35S:
ARR10 lines exhibited an increase in cell number compared with
wild type, consistent with hypersensitivity to endogenous cytokinin
resulting in greater cell proliferation in the shoot.
The hypersensitive ARR10 lines also exhibit an enhanced tran-
scriptional response to cytokinin (Fig. 1 G and H). The cytokinin-
mediated induction of ARR7, ARR15, and CKX5 and the repression
of HKT1 were examined (8, 20, 28, 29). ARR7 and ARR15 encode
type-A ARRs and are primary-response genes, CKX5 encodes a
cytokinin oxidase, and HKT1 encodes a gene whose product is re-
sponsible for removing sodium ions from the root xylem. The
cytokinin-dependent regulation of these genes is severely attenu-
ated in the cytokinin-insensitive arr1 arr12 mutant (the arr1 arr10
arr12 mutant was not used for comparison because its primary root
prematurely aborts) (Fig. 1G). Consistent with the physiological
responses to cytokinin, ARR10-GFP overexpression resulted in in-
creased transcript levels for ARR7, ARR15, and CKX5 and de-
creased transcript levels for HKT1 following cytokinin treatment at
all cytokinin concentrations examined, this effect being observed in
both the arr1 arr10 arr12 and wild-type backgrounds (Fig. 1 G and
H). The basal transcript level ofHKT1 was also substantially reduced
in the ARR10 transgenic lines, consistent with a heightened response
to endogenous cytokinin. Taken together, these results are consistent
with the hypothesis that the cytokinin hypersensitivity found in the
ARR10 lines is due to an enhanced ability to mediate cytokinin-
regulated gene expression. Furthermore, the use of the arr1 arr10
arr12 loss-of-function background appeared to result in a heightened
hypersensitivity compared with use of the wild-type background
based on the hypocotyl, root, and molecular response assays.
Genome-Wide Identification of Candidate Targets for ARR10. We
exploited the hypersensitive 35S:ARR10:GFP lines as a means to
identify direct targets of type-B ARRs by chromatin immunopre-
cipitation/DNA sequencing. For the ChIP-seq analysis, we exam-
ined the hypersensitive lines a1 (two biological replicates) and a2
(one biological replicate) following treatment for 30 min with 5 μM
6-benzylaminopurine (BA). A 30-min treatment was used because
transcriptional induction by cytokinin of primary targets can be
observed within 10 min and often peaks within 2 h (28). Binding
peaks were identified by model-based analysis of ChIP-seq
(MACS), with the peak summits defined as the point of local
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Fig. 1. 35S:ARR10:GFP lines exhibit hypersensitivity to cytokinin. (A) Cytokinin-hypersensitive lines expressing 35S:ARR10:GFP exhibit greater ARR10 expression
than wild type based on qRT-PCR analysis. Results for four independent lines of 35S:ARR10:GFP in the arr1;10;12 background (a1, a2, a3, and a4) and two in-
dependent lines in the wild-type background (w1 and w2) are shown. Expression was normalized to a tubulin (At5g62700) internal control, and is presented as
relative to the wild-type control. (A, Inset) Relative ARR10-GFP protein levels from 7-d-old seedlings based on immunoblot analysis with an anti-GFP antibody
(GFP-Ab); LC, loading control. (B) Hypocotyl growth dose–response assay to cytokinin (BA) (n = 30). Error bars indicate SE (not shown if smaller than symbol).
(C) Root growth dose–response assay to cytokinin (BA) (n = 30). The increase in root length from day 4 to 7 was measured. Error bars indicate SE (not shown if
smaller than symbol). (D) Primary root tips of 7-d-old wild-type and 35S:ARR10:GFP-a1 seedlings treated with DMSO vehicle (−) or 1 μM BA (+). (Scale bars,
0.2 mm.) (E and F) Hypersensitive lines have shorter roots due to effects on both root cell elongation (E) and cell proliferation (F). Root epidermal cell lengths
from the elongation zone (n ≥ 10; P < 0.05) and root apical meristem (RAM) size based on the number of cortex cells (n ≥ 5; P < 0.05) were determined for
7-d-old roots at the BA concentrations indicated. Error bars indicate SE. Same letters indicate no significant difference by an ANOVA applying Tukey HSD post
test (na, conditions with no data due to phenotypic severity). (G) 35S:ARR10:GFP lines exhibit a hypersensitive molecular response to cytokinin compared
with wild type (Wt) and the cytokinin-insensitive arr1 arr12 mutant in a dose–response analysis. Expression is plotted on a log10 scale. Relative transcript
levels of cytokinin-responsive genes from 6-d-old roots were examined by qRT-PCR. Seedlings were treated for 2 h with the indicated BA concentrations.
Expression was normalized to a tubulin (At5g62700) internal control, and is presented as relative to the Wt untreated control. Transcript levels of the
cytokinin-inducible genes ARR7, ARR15, and CKX5 and the cytokinin-repressed gene HKT1 were examined. Error bars indicate SE. (H) Analysis of 35S:ARR10:
GFP lines w1, w2, and a2 compared with wild type by qRT-PCR (oP < 0.05, ooP < 0.01, for comparison of BA treatment with untreated for each line, t test; *P <
0.05, **P < 0.01, for comparison of transgenic lines with the analogous wild-type treatment condition, one-way ANOVA with post hoc Holm multiple-
comparison calculation; n = 3).
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maximum read density (30). Substantial overlap was found for the
DNA regions bound in the three samples, with 4,861 summits in
common for all three samples (Fig. 2A). The peak summits were
found in introns, exons, and intergenic regions, the greatest number
of summits being found in the intergenic regions that would include
the gene promoters (Fig. 2B), this also being the case when nor-
malized per kilobase of region type (19% introns, 19% exons, 67%
intergenic regions). The maximum peak frequency occurred near
the transcription start sites (TSSs) (Fig. 2C), such binding being
consistent with a classic regulatory role for ARR10 in the control of
gene expression.
ARR10 is predicted to bind to DNA regions associated with the
type-A ARRs, which are cytokinin primary-response genes (8, 21,
22). As shown in Fig. 2D, ARR10 binding peaks are found asso-
ciated with the type-AARRs, with 9 out of 10 of the ARR10 binding
peak summits occurring in the promoter regions of the type-A
ARRs. The peaks exhibit a range of Q values, spanning much of
the frequency region defined by the overlapping set of 4,861 binding
sites. Thus, the ARR10-GFP ChIP-seq analysis extracts a set of
known targets (type-A ARRs), consistent with the ChIP-seq binding
sites being of functional significance.
ARR10 Binding Sites Identified by ChIP-Seq Are Enriched for Type-B
ARR DNA-Binding Motifs. ARR10 targets are predicted to be
enriched for type-B ARR-binding motifs. To characterize the DNA-
binding motifs for ARR1 and ARR10, we used the PBM11 protein-
binding microarray (31, 32). ARR1 bound with high affinity to
primary (AGATACGG; E score 0.49250), secondary (AAGATCTT;
E score 0.49080), and tertiary (CGGATCCG; E score 0.48626)
motifs (Fig. 2E). These motifs all contain a core (A/G)GAT se-
quence previously identified as critical and sufficient for type-B
ARR binding (14). The ARR10 protein fusion exhibited partial
insolubility with decreased binding efficiency to the protein-binding
microarray (PBM), yielding a background of high–G/C-content
probes. However, when this background is removed, the same
primary motif is identified for ARR10 as for ARR1 (Fig. 2E).
These three extended binding motifs are the same as those recog-
nized by the type-B response regulators ARR11 and ARR14 (32)
and are also consistent with the more abbreviated ARR-binding
motifs identified by Weirauch et al. (33), indicating that the sub-
family-1 type-B ARRs all share a similar DNA-binding specificity.
Sequences based on the primary, secondary, and tertiary DNA-
binding motifs for the type-B ARRs are all enriched at the
ARR10 binding sites identified by ChIP-seq (Fig. 2F), confirming
their physiological relevance. Although they were enriched for these
extended motifs, we note that many of the summits lack such mo-
tifs. These summits are likely to contain core regions (6 bp or less)
of the binding motif that, although sufficient for binding, are often
too short to be clearly diagnostic for enrichment or contain type-B
ARR binding sites diverged from the consensus.
DNA Binding of ARR10 Is Associated with Genes Transcriptionally
Regulated by Cytokinin. We identified 4,004 candidate gene tar-
gets based on their proximity to the ARR10 binding peaks
(Dataset S1), and refer to these as ARR10 candidate targets. Gene
targets were then identified by comparison with datasets for genes
that are differentially expressed (DE) in response to cytokinin. For
this purpose, we made use of an RNA-seq dataset derived from
whole seedlings (1,162 DE genes) (20), a new RNA-seq dataset
derived from roots (1,221 DE genes) and shoots (39 DE genes),
and two microarray datasets derived from shoot tissue (720 and
121 DE genes) (11, 20). We also compared the candidate targets to
the “golden list,” a set of genes identified by meta-analysis of
13 cytokinin transcriptome studies that represent robustly DE
genes (226 DE genes) (20). In addition, we took advantage of a
microarray study in which cytokinin-dependent gene regulation
was compared in wild type to the arr1 arr10 arr12 mutant (11),
incorporating genes that are differentially regulated between these
two genotypes into our analysis (1,001 DE genes). In all, 2,848
nonredundant DE genes were identified through these expression
Fig. 2. Global analysis of ARR10 candidate-target sites as revealed by ChIP-seq. Transgenic lines ARR10-GFP a1 (Exp1) and a2 (Exp2) were treated for 30 min with
5 μM BA, and ARR10 binding sites were identified by ChIP-seq using MACS analysis. (A) Proportional Venn diagram of summit regions in each sample with
4,861 summit regions common to all three samples. There was a high degree of overlap in ARR10 binding sites based on biological replicates (Exp1: Reps 1 and 2)
and independent transgenic lines (Exp1 and Exp2). The set of common summits is used for analysis in B–F unless otherwise indicated. (B) Bar chart presenting the
number of summit regions whose center lies in an intron, exon, or intergenic region; 26 summits are in areas where an exon from one model overlaps an intron
from another model. (C) ARR10 binding sites are enriched near transcriptional start sites. Dark bars show positions of each summit associating it with the closest
gene in the downstream direction. Blue bars show the relative location within the gene of all summit regions whose centers are within any gene. (D) High-affinity
binding sites for ARR10 are associated with type-A ARR genes. Histogram of Q values for binding sites identified in Exp2 following BA treatment. Light blue bars
represent all binding sites identified by MACS analysis; dark gray bars represent the 4,861 sites that are shared by all three samples (from A). Values for sites near
type-A ARRs are indicated. (E) Consensus DNA-binding motifs for ARR1 and ARR10 based on PBM analysis. (F) Type-B ARR DNA-binding elements are enriched at
the 200-bp ARR10 binding site “summits” defined by ChIP-seq compared with background. The bar chart shows the percentage of sequences that contain any
7-mer derived from the primary (AGATWCG), secondary (AAGATCTT), or tertiary (CGGATCCG) type-B ARR-binding motifs (P < 1 × 107 for all comparisons).
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studies. Of these, 804 corresponded to a candidate gene target
(Dataset S2); we refer to these 804 genes as ARR10 targets.
The ARR10 candidate targets were substantially enriched for
cytokinin DE genes based on our analysis of the golden list for
cytokinin-regulated gene expression as well as the RNA-seq
information. The golden list contains 158 up-regulated and
68 down-regulated genes (20). Of the up-regulated genes, 76 (48%)
correspond to an ARR10 candidate target; of the down-regulated
genes, 17 (25%) correspond to an ARR10 candidate target. For the
up-regulated DE genes, those supported by a higher number of
microarray experiments are more likely to be associated with an
ARR10 binding peak (Dataset S2). Overall, golden list genes are
more likely to be near ARR10 peaks than randomly chosen genes
(2.3% of the candidate genes have a golden list entry compared
with 0.7% predicted for a random occurrence), these genes are
more often up- than down-regulated, and ARR10 peaks are most
commonly upstream rather than internal to the golden list genes.
Similarly, in a comparison of the type-B ARR candidate targets
with 1,162 DE genes identified as cytokinin-regulated in an RNA-
seq analysis (20), 310 of the DE genes (26.7%) corresponded to an
Fig. 3. Enriched GO categories for ARR10 candidate and target genes. (A) GO analysis, showing representative responses that exhibit enrichment for candidate
and target genes. The% of candidate and target genes represented by each GO category is compared with the% expected frequency if not enriched. General GO
categories of responses are given with P values in parentheses. (B) Cytokinin regulates hormone responses through ARR10-mediated control of hormone bio-
synthesis, inactivation and degradation, transport, and signaling. ARR10 candidate genes are listed for the hormones cytokinin, auxin, and ABA. Targets con-
firmed by expression are in bold and highlighted red if induced by cytokinin, and blue if inhibited by cytokinin. (C) Distribution of transcription factor families
among candidate and target genes.
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ARR10 candidate target (significantly higher than the 14.5% pre-
dicted by chance), with 78.1% of the DE genes being up-regulated.
We characterized the cytokinin-induced and -repressed ARR10
target genes in terms of their position relative to the TSS and for
enrichment of type-B ARR-binding motifs (Fig. S3). There is no
apparent difference between the up- and down-regulated target
genes in terms of ARR10-binding location relative to the TSS, both
exhibiting what one might expect from a random selection from the
overall set of peak–gene associations. However, substantial differ-
ences are observed when we examine type-B ARRmotif enrichment
for the up- and down-regulated genes. The primary, secondary, and
tertiary ARR-binding motifs are enriched at binding sites near DE
genes (ARR10 targets), but this enrichment is mostly due to the
contribution from the up-regulated genes, which are enriched for all
three motifs (Fig. S3B). Interestingly, although the tertiary binding
motif is more rare, it alone of the three motifs exhibited significant
enrichment at binding sites among the down-regulated genes.
Gene Ontology Analysis. Gene ontology (GO) analysis for the
ARR10 targets and candidate targets revealed enrichment for
similar biological processes (Fig. 3A and Dataset S3). The similarity
of the GO-enriched processes suggests that the genes identified in
the ARR10 candidate-target dataset that lacked verification by
expression information (ARR10 target dataset) are also likely to be
of physiological relevance. Cytokinin-dependent regulation of their
expression may require additional regulatory factors, occur during
a different developmental state, or exhibit longer-term kinetics
for induction, because transcriptomic analyses have focused on
the short-term response to cytokinin. The GO analysis points to
extensive involvement of ARR10 in the control of hormonal
responses, including abscisic acid (ABA), auxin, gibberellin, cyto-
kinin, ethylene, brassinosteroids, jasmonic acid, and salicylic acid.
Examination of the targets associated with cytokinin, auxin, and
ABA reveals multiple regulatory points, including biosynthesis,
degradation/inactivation, transport, and signal transduction (Fig.
3B). These data point to the extensive cross-talk that can occur
between cytokinin and other hormonal signaling pathways in the
control of growth and development. The GO analysis also links
ARR10 activation, and hence cytokinin, to both abiotic (salt and
drought stress, cold, and light) and biotic stimuli (Fig. 3A).
Our data also support a transcriptional cascade operating in the
cytokinin signaling pathway based on GO analysis for molecular
function, in which “sequence-specific DNA-binding transcription
factor activity” (GO:0003700) is the most highly enriched category.
This is the case for both the ARR10 candidate target (11.3% of
the genes compared with 6.6% expected; P value 2.1E-18) and
ARR10 target (15.2% of the genes compared with 6.6% expected;
P value 2.2E-13) genes. Multiple families of transcription factors
Fig. 4. Cytokinin-dependent binding of ARR10 to promoter regions of targets. (A) Immunoblot analysis for ARR10-GFP in input and ChIP samples with anti-GFP
antibody. (B) Cytokinin induction of ARR10 binding to DNA. Boxplot analysis for ARR10 binding to peaks associated with induced or repressed genes (All) as well as
the subset of those genes that belong to the golden list (Gold) (20). Fold enrichment is calculated based on the amount of binding found in the presence of
cytokinin relative to that in the absence of cytokinin and is log2-transformed. (C) Representative binding profiles based on the IGB viewer for cytokinin induction of
ARR10 binding to selected genes whose expression is induced in response to cytokinin. Fold enrichment for each sample (IP/input) was computed by MACS using
bdgcmp. The range starts at 1 (IP = input), and the maximum varies per panel (12.9 for ARR5; 23 for ARR7; 12.4 for ARR15; 6.5 for SHY2; 8.6 for UBC16). (D) ChIP–
qRT-PCR to confirm cytokinin-enhanced binding of ARR10-GFP to target genes in the 35S:ARR10:GFP transgenic line (n = 3; error bars indicate SE). *P < 0.05, **P <
0.01, for comparison of BA treatment with untreated for each line, t test. (E) ChIP–qRT-PCR demonstrating cytokinin-enhanced binding to target genes by Myc-
ARR10 from the pARR1:Myc-ARR10 transgenic line (n = 2). Numbers give fold enrichment for binding in response to BA. (F) Representative binding profiles for
ARR10 binding to selected genes whose expression is repressed in response to cytokinin. Fold-enrichment range (IP/input) is from 1 to 4 for each panel.
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are implicated as ARR10 targets, with members of the bHLH,
AP2-EREBP, and WRKY families being among the most abun-
dant (Fig. 3C). Additionally, when the transcription factor (TF)
subset of genes is examined based on GO analysis for biological
processes, we find the TF gene sets are implicated in the same
types of responses found for the overall ARR10 candidate-target
and target genes (e.g., responses to organic substances, hormones,
abiotic stimuli, light, and other organisms). This supports a model
in which type-B ARR regulation of these processes is controlled in
part by regulation of the expression of additional TFs that then
provide specificity to the downstream responses.
ARR10 Exhibits Cytokinin-Dependent Binding to DNA Targets. To de-
termine how cytokinin regulates the DNA binding for the type-B
ARRs, ChIP-seq for 35S:ARR10:GFP (line a2) was performed in the
absence or presence of cytokinin (BA). Cytokinin did not affect the
protein levels of ARR10-GFP protein under the conditions used for
ChIP (Fig. 4A). The ChIP-seq analysis revealed cytokinin treatment
resulting in an overall increase in DNA binding for ARR10. There was
a 2.32-fold enrichment on average for binding to targets and a
2.05-fold enrichment for binding to candidates in response to cytokinin.
Cytokinin-dependent binding for ARR10 was particularly pro-
nounced for target genes induced by cytokinin (Fig. 4B and Fig.
S3C). The ChIP-seq binding profiles for ARR10, in the absence and
presence of cytokinin, for a select group of induced genes are shown
in Fig. 4C. Binding profiles are shown for the type-A response
regulators ARR5, ARR7, and ARR15, primary-response genes all of
which have a type-B ARR binding site(s) located near the TSS.
Binding profiles are also shown for SHY2, a primary-response gene
that encodes a regulator of auxin responses (23) and that has two
separate peaks of ARR10 binding in its promoter. Similarly,
UBC16, which encodes an F-box protein whose expression is re-
producibly induced in response to cytokinin (20), also has two
separate peaks in its promoter. In all these cases, although the basal
level of binding varies, there is a substantial increase in binding
following the 30-min treatment with exogenous BA.
Fig. 5. WUSCHEL is a type-B ARR target. (A) Cytokinin induces binding of ARR10 to the WUS promoter based on ChIP-seq analysis. Fold enrichment (IP/input)
range is from 1 to 8 for each panel. (B) 35S:ARR10:GFP lines exhibit hypersensitive induction of WUS expression by cytokinin compared with wild type and the
cytokinin-insensitive arr1 arr10 arr12 mutant. Expression was determined by qRT-PCR in 4-d-old green seedlings exposed for 0, 2, or 24 h to 10 μM BA. Cytokinin
induction of the primary-response genes ARR7 and ARR15 is shown for comparison. Expression was normalized to a tubulin (At5g62700) internal control, and is
presented as relative to the wild-type untreated control. Error bars indicate SE. Red letters are for statistical comparison between genotypes at each of the three
time points, and blue letters are for statistical comparison over time within each genotype; same letters indicate no significant difference (ANOVA with post hoc
Holmmultiple-comparison calculation; P < 0.05; n = 3). (C) Cytokinin induction ofWUS expression is suppressed in single and double type-BARRmutants. qRT-PCR
and statistical analyses were performed as in B. (D) Analysis of callus and shoot growth on CIM media. (D, Left) 2,4-D, 10 μg/L. (D, Right) 2,4-D, 30 μg/L. Kinetin
concentrations are indicated. Pictures were taken after 4-wk growth of the hypocotyl explants. (E) qRT-PCR showing the effect on expression ofWUS and CLV3.
RNA was isolated from hypocotyls immediately after excision (0 d) or following 7- and 14-d incubation on CIM containing 100 μg/L kinetin and 10 μg/L 2,4-D. Error
bars indicate SE (*P < 0.05, **P < 0.01, for comparison of mutant lines with wild type at each time point; one-way ANOVA with post hoc Holm multiple-
comparison calculation; n = 3).
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We used ChIP–qRT-PCR to confirm the cytokinin-dependent
binding of ARR10 to these five targets (ARR5, ARR7, ARR15,
SHY2, and UBC16) in line a2 (Fig. 4D). Similarly, we also con-
firmed cytokinin induction of ARR10 binding to these targets by
using a separate transgenic expression line, in this case an ARR1:
ARR10-Myc line (Fig. 4E). Here ARR10 expression is driven from
the ARR1 promoter, resulting in lower and more restricted ex-
pression than is found using the CaMV 35S promoter (26). Thus,
these ChIP-based analyses demonstrate that cytokinin stimulates
ARR10 binding to the promoters of primary targets, consistent
with a model in which cytokinin-mediated posttranslational changes
(e.g., phosphorylation of the receiver domain) regulate the DNA
target affinity of ARR10.
There is also a trend toward increased binding of ARR10 for
those targets repressed by cytokinin (Fig. 4B and Fig. S3C), although
this is not as pronounced as for the induced genes, suggesting the
involvement of other regulatory factors and/or longer-term kinetics
for such changes to occur. We confirmed cytokinin-dependent
binding of ARR10 to the promoter region of SCL3 and to an in-
tron of AUX1 (Fig. 4 D and F), having recently shown that cyto-
kinin inhibits the expression of AUX1 (34).
Type-B ARRs Target WUSCHEL to Control Shoot Initiation. WUSCHEL
(WUS) is among the genes revealed to be a candidate target of
ARR10 based on the ChIP-seq analysis (Fig. 5A). WUS is a
homeodomain transcription factor that plays a key role in the es-
tablishment and maintenance of the shoot apical meristem (SAM)
(35, 36). Previous work has demonstrated a role of cytokinin in
maintaining activity of WUS within the organizing center of the
SAM, with WUS expression increasing in response to exogenous
cytokinin application (37). However, it was not previously known
whether WUS was a direct target for the type-B ARRs. Our ChIP-
seq analysis reveals a cytokinin-dependent binding peak for
ARR10 upstream of the WUS TSS, consistent with classical reg-
ulation ofWUS gene induction by ARR10. This region of theWUS
promoter does not contain extended type-B binding motifs (Fig.
2E), but does contain shorter core type-B ARR binding sites that,
as noted earlier, are sufficient for interaction (14).
Cytokinin-dependent binding of ARR10 to the WUS promoter
suggests a role for type-B ARRs in regulating WUS expression. We
performed a functional analysis of this hypothesis with the type-B
ARR loss-of-function mutants as well as the 35S:ARR10:GFP hy-
persensitive lines (Fig. 5 B and C). Treatment of wild-type seedlings
with cytokinin induces the expression of WUS, but the kinetics of
WUS induction differs markedly from that of the well-characterized
type-A ARRs that, like many other cytokinin-regulated primary-
response genes, exhibit a rapid induction that peaks within a few
hours of treatment and then decreases (28); WUS exhibited sub-
stantially higher expression after a 24-h compared with a 2-h cyto-
kinin treatment (Fig. 5 B and C). Cytokinin induction of WUS was
abolished in the cytokinin-insensitive triple mutant arr1 arr10 arr12
and accentuated in the 35S:ARR10:GFP hypersensitive lines, these
last exhibiting a pronounced elevation in WUS expression at 24 h
compared with wild type (Fig. 5B). Analysis of single- and double-
mutant combinations of type-B ARRs supports functional overlap in
the gene family such that ARR1, ARR10, and ARR12 all play roles in
mediating the cytokinin-dependent induction of WUS (Fig. 5C).
Based on the hypersensitivity of the 35S:ARR10:GFP lines to
cytokinin, coupled with the cytokinin-dependent binding of ARR10
to WUS, we predicted that the lines might exhibit altered shooting
ability. We explored this possibility in tissue culture, as cytokinin
plays a critical role in the induction of WUS expression and the
induction of shooting in tissue culture (38). Hypocotyls from 35S:
ARR10:GFP lines a1 and a2 both formed shoots on callus-
induction medium (CIM) (Fig. 5D), bypassing the usual require-
ment for movement onto shoot-induction medium (SIM). This
ability to form shoots on CIM occurred across a limited range of
auxin and cytokinin concentrations. Notably, under the low auxin
concentration (10 μg/L 2,4-D) used, the other lines demonstrated
little or no ability to form callus much less shoots, regardless of the
cytokinin level. These other lines included a wild-type control as
well as the cytokinin-insensitive lines arr1 arr12 and arr1 arr10 arr12.
In addition, we did not observe shooting with the 35S:ARR10:GFP
lines in the wild-type background, only in the arr1 arr10 arr12
background (Fig. 5D). On CIM containing a higher level of auxin
(30 μg/L 2,4-dichlorophenoxyacetic acid; 2,4-D), no shooting was
observed, only callus formation (Fig. 5D). The cytokinin-insensitive
lines exhibited a decreased ability to form callus in comparison
with wild type as predicted. The 35S:ARR10:GFP lines exhibited
greater levels of callus formation than wild type at the lower cy-
tokinin concentrations (0 to 30 μg/L kinetin) but reduced callus
formation in comparison with wild type at the higher cytokinin
concentrations (100 to 1,000 μg/L kinetin). No callus or shoot
formation was observed when hypocotyls were placed on CIM
lacking the auxin 2,4-D.
We examined the molecular characteristics coinciding with shoot
induction in 35S:ARR10:GFP lines a1 and a2, the prediction being
that these would exhibit heightened expression of key genes in-
volved in the production of the SAM. For this purpose, hypocotyls
were placed on CIM containing 10 μg/L 2,4-D and 100 μg/L ki-
netin, conditions under which we observed good shoot formation in
the transgenic lines (Fig. 5D). At 7 d, the transgenic lines had
initiated callus growth at the ends of the hypocotyl explants but did
not yet display greening or shoot formation. By 14 d, callus had
begun to green and form leaves. WUS expression was slightly ele-
vated in hypocotyls of the 35S:ARR10 lines before incubation on
CIM, and was hyperinduced in the transgenic lines after transfer to
CIM (Fig. 5E). CLV3, which is induced in response to WUS (38),
was also hyperinduced in the transgenic lines in comparison with
the wild-type control when placed on CIM (Fig. 5E). The ability of
cytokinin to induceWUS expression was lost in the arr1 arr10 arr12
triple mutant (Fig. 5E). These data are thus consistent with cyto-
kinin stimulating shoot formation in the hypersensitive lines
through type-B ARR-mediated up-regulation of WUS expression.
Discussion
In this study, we took advantage of the enhanced stability of
ARR10 compared with the other type-B ARRs to generate
Arabidopsis lines hypersensitive to cytokinin and clarify the role of
cytokinin in regulation of various physiological responses. We used
protein-binding microarrays to characterize the DNA binding sites
for ARR1 and ARR10. Finally, we used ChIP-seq in conjunction
with transcriptome analysis to identify the cytokinin-dependent
targets for ARR10, thereby defining a crucial link between the
cytokinin primary-response pathway and the transcriptional changes
that mediate physiological responses to this phytohormone. As
discussed below, results from our analyses shed light on the physi-
ological role of the type-B ARRs in regulating the cytokinin re-
sponse, the mechanism of type-B ARR activation, and the basis by
which cytokinin regulates diverse aspects of growth and develop-
ment as well as responses to biotic and abiotic factors.
Type-B response regulators are limiting for signal transduction, as
increasing the expression level results in hypersensitivity to cytoki-
nin. Changes in sensitivity have been previously noted following
ectopic and/or heightened expression of type-B ARRs (8, 26).
Heightened levels of ARR10 affect diverse cytokinin responses,
including physiological responses such as hypocotyl and root growth,
cell number and size in leaves, and shoot regeneration in tissue
culture, as well as the molecular response based on cytokinin-
dependent regulation of gene expression. Cytokinin hypersensitiv-
ity affected cell expansion and division differentially during leaf
development. An increase in cell size was the predominant effect on
earlier leaves; interestingly, a historical bioassay for cytokinin activity
is the ability to enhance cell expansion in cotyledons, consistent with
such an effect on younger tissue (39). An increase in cell number
was the predominant effect of hypersensitivity on later leaves, with a
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substantial increase in leaf area compared with wild type occurring with
the later leaves. A role of type-B ARRs in regulating both cell number
and cell size is consistent with loss-of-function analysis, both loss- and
gain-of-function approaches indicating a greater role overall for the
type-B ARRs in control of cell proliferation than for cell expansion. A
decrease in leaf cell number has also been noted in cytokinin-deficient
as well as cytokinin-insensitive ahk receptor mutant plants (40, 41). Our
results also point to competition among the type-B ARRs for target
binding and gene regulation, based on the finding that ARR10 exhibits
a greater hypersensitive response in a mutant background lacking
ARR1 and ARR12 than in the wild-type background. The enhanced
stability of ARR10 compared with ARR1 and ARR12may result in its
exhibiting greater transcriptional activity (17, 26).
ARR10 bound DNA in a cytokinin-dependent manner, sup-
porting a binding mechanism similar to that of the prokaryotic
response regulators. Like the type-B ARRs, many prokaryotic re-
sponse regulators contain a receiver domain and a separate DNA-
binding domain. The receiver domain is autoinhibitory, phosphor-
ylation on the conserved Asp residue resulting in a conformational
change to an “active” state that allows for binding to target se-
quences (42). Similarly, according to this model, Asp phosphory-
lation of the type-B ARRs in response to cytokinin would relieve
autoinhibition by the receiver domain and allow for binding of the
Myb-like domain to target sequences containing the conserved
binding motifs. Consistent with such a model is the fact that type-B
ARR proteins are present independent of cytokinin, regulation of
type-B ARR activity being primarily through phosphorylation
rather than turnover (16, 43); this contrasts with a hormone-
regulated transcriptional activator such as EIN3 involved in ethylene
signaling, which is stabilized in the presence of ethylene (44).
Targets for ARR10 include both up- and down-regulated genes,
consistent with the type-B ARRs being required for both induction
and repression of cytokinin-dependent gene expression (11). Al-
though ARR10 binding sites are enriched near the TSS for both
up- and down-regulated genes, the extended type-B ARR-binding
motifs as determined by PBM analysis were primarily enriched for
the up-regulated genes, suggesting that the type-B ARRs exhibit
higher affinity for these up-regulated targets. Binding to the down-
regulated targets may thus involve binding to the minimal type-B
ARR motif (14), with affinity increased by additional transcrip-
tional regulators that provide specificity for negative regulation, the
type-B ARRs not having apparent repressor activity themselves.
GO analysis of the ARR10 targets is consistent with the
pleiotropic nature of cytokinin. Binding targets relate to hor-
monal control of growth and development, as well as interactions
that control various biotic and abiotic responses. These roles
have been previously reported for cytokinin (1, 2), and one
fundamental question has been how a signaling molecule medi-
ates such a diverse array of outputs and how these response
pathways are integrated with other inputs. Analysis of our
binding data supports several transcriptional mechanisms in-
volved in cytokinin pleiotropy. First, subnetworks of gene targets
are identified that mediate hormonal cross-talk with cytokinin to
control growth and development, as well as to how cytokinin
mediates responses to biotic and abiotic stimuli. For example,
hormonal cross-talk by cytokinin is mediated by the regulation
of gene expression involved in the biosynthesis, degradation/
inactivation, transport, and signal transduction of multiple other
phytohormones. Not only does cytokinin regulate the activity of
other hormones, the cytokinin-dependent binding of ARR10 to
primary targets and resulting changes in expression (e.g., CKXs,
IPT, type-A ARRs) will negatively regulate cytokinin activity
itself, thereby allowing for desensitization and adaptation to the
hormone. Second, transcription factors were highly enriched
among the ARR10 targets, consistent with the type-B ARRs
operating at the top of a transcriptional cascade in the cytokinin
signaling pathway (11, 20). The transcription factors can serve as
another means to indirectly regulate subnetworks for particular
responses. In addition, they may function with the type-B ARRs
to combinatorially regulate expression of targets, as recently
found with a DELLA protein (45), which can allow for greater
specificity in regulation.
We identified WUS as a direct target of ARR10, functional
analysis indicating that ARR1, ARR10, and ARR12 all regulate its
expression.WUS encodes a homeodomain TF that plays a key role
in the establishment and maintenance of the shoot apical meristem
(35, 36).WUS is transcriptionally induced by cytokinin but does not
generally appear in large-scale transcriptomic studies of cytokinin-
regulated genes, likely due to its limited region of expression and
long-term kinetic response to the hormone. By enhancing expres-
sion of ARR10, we increased the sensitivity of WUS expression to
cytokinin and affected WUS-dependent transcriptional processes.
Interestingly, the homeobox TFs were more enriched in the
ARR10 candidate-target dataset than the ARR10 target dataset,
these often being genes such asWUS that are tightly regulated and
function within limited tissues and at specific stages of develop-
ment to control morphogenesis; for example, PHABULOSA is only
in the ARR10 candidate-target dataset, but its expression has been
found to be repressed by cytokinin to regulate cell proliferation at
the root meristem (46). Heightened expression of WUS in the
ARR10 cytokinin-hypersensitive lines facilitated shoot induction,
pointing to how modulation of cytokinin sensitivity may serve as a
means to enhance plant regeneration in tissue culture.
Materials and Methods
Detailed materials and methods are described in SI Materials and Methods.
Plant Materials, Growth Conditions, and Growth Assays. Wild-type and the
arr1-3 arr12-1 and arr1-3 arr10-5 arr12-1 mutant lines of A. thaliana were
grown as previously described (11). To generate the 35S:ARR10:GFP construct,
a genomic copy of ARR10 was amplified (Table S1) and recombined into
pEarleygate103 (47), and the construct was then introduced into wild type and
the arr1-3 arr10-5 arr12-1 triple mutant (48). Effects of cytokinin on root and
hypocotyl growth were assayed as described (9, 11). Root meristem size was
determined by counting cortical cell number as described (49).
Expression Analysis. Quantitative real-time PCR was performed using SYBR
Premix Ex Taq (TaKaRa Bio; RR041A) with primer pairs for the genes of interest
(Table S1) and β-TUBULIN3 (At5g62700) as a normalization control. RNA-seq to
examine the cytokinin response in wild-type seedlings was performed as de-
scribed (20), but roots and shoots were separated following cytokinin treat-
ment and processed independently; sequence data are available from the
National Center for Biotechnology Information (NCBI) Sequence Read Archive
under BioProject no. PRJNA286779.
Protein-Binding Microarrays. The DNA-binding domains from ARR1 and ARR10
were amplified from Arabidopsis cDNA (Table S1) and cloned into pMAL-c2x
(New England Biolabs), and the DNA-binding specificities were determined
using protein-binding microarrays (PBM11) (31, 32).
Chromatin Immunoprecipitation and Analysis. Seedlings were grown for 2 to
3 wk and then treated with either 5 μM BA or a DMSO vehicle control in liquid
media for 30 min to examine cytokinin induction. Tissue cross-linking, chro-
matin isolation, and immunoprecipitation were performed as described (50).
ChIP-seq was performed with line a1 (two biological replicates treated with
cytokinin) and line a2 (treated with and without cytokinin) of 35S:ARR10:GFP in
the arr1 arr10 arr12 background. Sequencing read information is given in Table
S2. Sequence data are available from the NCBI Sequence Read Archive under
BioProject no. PRJNA263839. ChIP-seq data may also be accessed through the
Quickload server for the open-source Integrated Genome Browser (IGB) to aid
in visualization (bioviz.org) (51). Peaks were called by comparing the IP with the
input derived from each sample separately using MACS2 (version 2.1.0) (30).
Summit regions were defined by restricting peaks to 100 bp in either direc-
tion. Overlapping summit regions from different samples were merged using
BEDTools (52), and a consensus peak defined whether this merged overlap
included all three cytokinin-treated samples. The 4,861 ARR10 consensus peaks
were associated with genes (“candidate targets;” Dataset S1) based on the closest
downstream gene from each strand within 1.5 kb of the binding summit, as
well as accepting any gene to which the peak was internal. Candidate-gene
targets were correlated with several cytokinin expression datasets (Dataset S2)
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(11, 20). GO analysis was performed using VirtualPlant 1.3 (virtualplant.bio.nyu.
edu/cgi-bin/vpweb/) (53). For ChIP–qRT-PCR, two or three biological replicates
were examined as indicated, with TUA4 (AT1G04820), TUB3 (AT5G62700), and
EIF4A1 (AT3G13920) as controls.
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